The Propanc Biopharma (PPCB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 344,900.00%, with a year-to-date return of 1,724,900.00%. In the past month, the stock has decreased 48.04%, reflecting recent market activity.
As of the latest close, Propanc Biopharma traded at $3.45 with a market cap of $69 thousand and volume of 1,970 shares. Five years ago, the stock traded at a split-adjusted price of $2.50, representing a 38.00% increase over that period. At the time, it had a market cap of $118 thousand and a volume of 17,331 shares.